MTUS1
Basic information
Region (hg38): 8:17643795-17801094
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MTUS1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 36 | 47 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 36 | 8 | 6 |
Variants in MTUS1
This is a list of pathogenic ClinVar variants found in the MTUS1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-17645940-T-C | not specified | Likely benign (Jan 30, 2024) | ||
8-17645951-G-A | not specified | Uncertain significance (Apr 17, 2024) | ||
8-17645951-G-C | not specified | Uncertain significance (Sep 20, 2023) | ||
8-17645955-A-G | not specified | Uncertain significance (Dec 06, 2022) | ||
8-17645958-A-G | not specified | Uncertain significance (Oct 04, 2022) | ||
8-17646034-G-C | not specified | Uncertain significance (Jan 12, 2024) | ||
8-17646089-G-A | not specified | Uncertain significance (Mar 28, 2024) | ||
8-17646096-T-C | not specified | Uncertain significance (Dec 05, 2022) | ||
8-17649946-A-G | not specified | Uncertain significance (Jun 07, 2024) | ||
8-17653211-C-G | not specified | Uncertain significance (Jul 16, 2021) | ||
8-17653215-T-C | not specified | Uncertain significance (Jul 13, 2022) | ||
8-17653217-T-A | not specified | Uncertain significance (Apr 06, 2024) | ||
8-17653257-C-G | Likely benign (Jan 01, 2023) | |||
8-17653271-T-C | not specified | Likely benign (Dec 17, 2023) | ||
8-17653275-T-C | not specified | Uncertain significance (Dec 11, 2023) | ||
8-17653432-G-A | not specified | Uncertain significance (Jan 04, 2024) | ||
8-17653465-G-A | not specified | Uncertain significance (Aug 30, 2021) | ||
8-17654567-G-C | not specified | Uncertain significance (Mar 24, 2023) | ||
8-17654573-C-T | not specified | Likely benign (Feb 26, 2024) | ||
8-17654660-T-G | not specified | Uncertain significance (Dec 17, 2021) | ||
8-17655866-C-G | not specified | Uncertain significance (Apr 08, 2024) | ||
8-17655903-A-G | not specified | Uncertain significance (Jan 10, 2022) | ||
8-17655929-C-A | not specified | Uncertain significance (May 02, 2024) | ||
8-17655975-T-C | Benign (Apr 12, 2018) | |||
8-17655981-T-C | not specified | Uncertain significance (Dec 17, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MTUS1 | protein_coding | protein_coding | ENST00000262102 | 14 | 157123 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.58e-11 | 1.00 | 124710 | 0 | 84 | 124794 | 0.000337 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -5.93 | 1063 | 640 | 1.66 | 0.0000328 | 8305 |
Missense in Polyphen | 256 | 161.06 | 1.5895 | 2322 | ||
Synonymous | -3.71 | 325 | 250 | 1.30 | 0.0000140 | 2391 |
Loss of Function | 3.33 | 26 | 51.9 | 0.501 | 0.00000259 | 712 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000152 | 0.000152 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00268 | 0.00262 |
Finnish | 0.0000930 | 0.0000928 |
European (Non-Finnish) | 0.000203 | 0.000203 |
Middle Eastern | 0.00268 | 0.00262 |
South Asian | 0.000196 | 0.000196 |
Other | 0.000331 | 0.000330 |
dbNSFP
Source:
- Function
- FUNCTION: Cooperates with AGTR2 to inhibit ERK2 activation and cell proliferation. May be required for AGTR2 cell surface expression. Together with PTPN6, induces UBE2V2 expression upon angiotensin-II stimulation. Isoform 1 inhibits breast cancer cell proliferation, delays the progression of mitosis by prolonging metaphase and reduces tumor growth. {ECO:0000269|PubMed:12692079, ECO:0000269|PubMed:19794912}.;
- Disease
- DISEASE: Hepatocellular carcinoma (HCC) [MIM:114550]: A primary malignant neoplasm of epithelial liver cells. The major risk factors for HCC are chronic hepatitis B virus (HBV) infection, chronic hepatitis C virus (HCV) infection, prolonged dietary aflatoxin exposure, alcoholic cirrhosis, and cirrhosis due to other causes. {ECO:0000269|PubMed:16650523}. Note=The gene represented in this entry may be involved in disease pathogenesis.;
Recessive Scores
- pRec
- 0.105
Intolerance Scores
- loftool
- 0.832
- rvis_EVS
- 2.1
- rvis_percentile_EVS
- 97.87
Haploinsufficiency Scores
- pHI
- 0.164
- hipred
- N
- hipred_score
- 0.369
- ghis
- 0.398
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.873
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mtus1
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; neoplasm; immune system phenotype; renal/urinary system phenotype; digestive/alimentary phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype; cellular phenotype;
Gene ontology
- Biological process
- regulation of macrophage chemotaxis
- Cellular component
- extracellular space;nucleus;nucleolus;cytoplasm;mitochondrion;Golgi apparatus;microtubule organizing center;spindle;microtubule;plasma membrane;microtubule cytoskeleton
- Molecular function
- microtubule binding